Large Group Aggregate Rates and Prescription Drug Cost Transparency
The Department of Managed Health Care conducts an annual public meeting regarding large group aggregate rates as required by Senate Bill 546 (Leno, Chapter 801, Statutes of 2015) and on prescription drug costs transparency pursuant to Senate Bill 17 (Hernandez, Chapter 603, Statutes of 2017). The meeting provides an opportunity for a public discussion regarding the reasons for changes in the rates, benefits, and cost sharing in the large group market as well as prescription drug costs in the commercial market.
Next Meeting:
Date:
Location:
Meeting Materials:
Presentations:
Upcoming Meeting:
March 5, 2020
Agenda
Previous meeting agendas, minutes and presentations:
March 12, 2019
Agenda
February 7, 2018
Agenda
Presentations:
February 1, 2017
Agenda
Presentations: